Skip to main content

Table 1 Baseline characteristics of the patients

From: The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus

Variable

Frequency (%)

Mean ± SD

AGEs (Mean ± SD)

P-value

Age group (years)

   ≥ 40

22 (7.5%)

55.09 ± 10.00

71.66 ± 12.23

0.428

 40–60

178 (60.8%)

75.40 ± 11.73

 ≤ 60

93 (31.7%)

74.71 ± 14.70

BMI (kg/m2)

 < 25

64 (21.8%)

27.38 ± 3.95

77.79 ± 11.89

0.016*

 25–30

116 (39.6%)

75.78 ± 12.45

 ≥ 30

113 (38.6%)

72.36 ± 13.22

Central obesity

 No

131 (44.7)

NA

75.61 ± 12.31

0.725

 Yes

162 (55.3)

75.12 ± 13.18

Smoking

 No

281 (95.9%)

NA

74.47 ± 12.74

0.004*

 Yes

12 (4.1%)

85.14 ± 9.23

FBS (mg/dL)

 < 126

26 (8.9%)

186.05 ± 61.19

71.88 ± 13.5

0.207

 ≥ 126

267 (91.1%)

75.19 ± 12.6

HbA1C (%)

 < 7%

86 (29.4%)

8.18 ± 1.87

73.55 ± 12

0.323

 7–9%

126 (43%)

74.78 ± 13.4

 ≥ 9%

81 (27.6%)

76.52 ± 12.4

SBP (mmHg)

 < 140

219 (74.7%)

125.73 ± 19.79

74.20 ± 12.3

0.107

 ≥ 140

74 (25.3%)

76.97 ± 13.8

DBP (mmHg)

 < 90

240 (81.9%)

77.82 ± 10.56

74.10 ± 12.2

0.045*

 ≥ 90

53 (18.1%)

78.52 ± 14.6

Therapeutic agent

 OHA

180 (61.4%)

NA

74.60 ± 12.18

0.326

 Insulin

41 (14%)

76.21 ± 14.44

 Insulin + OHA

72 (24.6%)

74.93 ± 13.39

Cholesterol (mg/dL)

 < 200

177 (60.4%)

190.42 ± 42.25

74.38 ± 12.8

0.389

 ≥ 200

116 (39.6%)

75.70 ± 12.6

Triglycerides (mg/dL)

 < 150

149 (50.9%)

166.84 ± 80.36

75.04 ± 12.5

0.849

 ≥ 150

144 (49.1%)

75.75 ± 13.0

LDL (mg/dL)

 < 100

114 (38.9%)

111.13 ± 33.44

74.13 ± 13.0

0.411

 ≥ 100

179 (61.1%)

75.39 ± 12.5

HDL (mg/dL)

 < 40

82 (28%)

45.38 ± 9.61

77.34 ± 13.3

0.042*

 ≥ 40

211 (72%)

73.95 ± 12.4

  1. AGEs, advanced glycation end-products; BMI; Body mass index; FBS; Fasting blood sugar; HbA1C, hemoglobin A1c; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; OHA, Oral hypoglycemic agents; LDL, low-density lipoprotein; HDL, high-density lipoprotein
  2. *P < 0.05